Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WSAVA names new Executive Board director
Dr Nalinika Obeyesekere co-founded Sri Lanka's first multi-vet companion animal practice.

Dr Nalinika Obeyesekere will represent the Asia-Oceania region for one year.

The World Small Animal Veterinary Association (WSAVA) has announced the appointment of Sri Lankan veterinary surgeon, Dr Nalinika Obeyesekere, to its board of executives.

Dr Obeyesekere co-founded Sri Lanka's first multi-vet companion animal practice, the PetVet Clinic, and is a co-founder of the Society of Companion Animal Practitioners of Sri Lanka. She also serves as the CEO of the Blue Paw Trust, a Sri Lankan charity dedicated to animal welfare.

In 2018, she was honoured with the inaugural WSAVA Award for Companion Animal Welfare for her efforts to improve standards of veterinary care in the country. Dr Obeyesekere will represent the Asia-Oceania region for one year on the WSAVA Executive Board under a by-law that states it may appoint an additional member. 

WSAVA President Dr Ellen van Nierop said: “Dr Obeyesekere’s passion for raising standards of veterinary care and her knowledge and experience of working in Asia make her an outstanding addition to our Executive Board, which now includes members from every region of the world.”

The WSAVA has also announced the appointment of new members to two of its key Clinical Committees - the Therapeutics Guidelines Group (TGG) and the Global Pain Council (GPC).

The Therapeutic Guidelines Group (TGG) works to ensure best practices for the choice and use of veterinary medications, including their efficacy, accessibility, and responsible use in companion animals. It achieves this with the assistance of WSAVA members and stakeholders under the concept of One Health.

The new members of the TGG are:

  • Dr Fergus Allerton, UK
  • Dr Pawel Beczkowski, Hong Kong
  • Dr Jennifer Granick, USA
  • Dr Ana Martins Mateus, Belgium. 

The WSAVA Global Pain Council strives to raise standards for the management of pain around the world and recently launched a set of updated WSAVA Global Guidelines. The following new members have been appointed:

  • Professor Adetola Rasheed Ajadi, Nigeria
  • Dr Conny Mosley, Canada
  • Dr Nameeta Nadkarni, India
  • Dr Mike Petty, USA.

Image (C) WSAVA

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.